EXTRA FIRMING day cream all skin types SPF15 50 ml

€107.50
Tax included
Quantity

  Security policy

(edit with the Customer Reassurance module)

  Delivery policy

(edit with the Customer Reassurance module)

  Return policy

(edit with the Customer Reassurance module)

The innovative firming day cream of the latest generation integrates a unique [COLLAGEN]³ TECHNOLOGY alongside three powerful pro-collagen components: collagen polypeptides, pecan tree extract, and organic mitracarpus extract. These ingredients collaborate to enhance collagen’s quantity, quality, and structure, potentially boosting its reserves by as much as 53%**. Within a mere 7 days*, users will notice a significant increase in skin firmness, a lifting action that reshapes facial features, as well as reduction in wrinkles and enhanced cheekbone volume. Furthermore, it contains niacinamide, often referred to as the youth molecule, which aids in evening out skin tone and increasing luminosity. The soothing texture, developed by Clarins Laboratories, ensures a comfortable application without leaving an oily residue, and the refillable design supports our sustainability goals. This cream aims to rejuvenate and firm the skin, grounded in scientific advancements and confirmed outcomes. *Consumer feedback from the Extra-Firming Jour & Nuit trial, involving 107 participants. **Ex vivo analysis conducted on skin samples. ***A Clarins exclusive. Advantages include: Improved firmness, refined facial contours, diminished wrinkles, enhanced cheekbone definition, hydration, and a youthful glow.
CLARINS
825-72684
120 Items

Data sheet

Gender
Woman
CompleteFamilies
Cosmética Facial/Tratamientos Faciales
Contenido
50 ml
Tendencias
Aloe Vera
Argán
Colágeno
Niacinamida
Green Beauty
Ingredientes naturales
Packaging sostenible
Recarga y rellenable
Texturas
Crema
Ingredientes
Aloe Vera
Argán
Colágeno
Niacinamida
Piel
Todo Tipo de Pieles
Edad
Más de 50 años
Protección SPF
Media SPF 15
Tratamiento
Día

Specific References

EAN13
3666057272684
Comments (0)
No customer reviews for the moment.